+576.5%
GSK vs NBIX
+1,201.8%
-625.3%
-51.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | NBIX | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -0.2% | +0.2% | 0.0% |
| 7D | -3.5% | +0.4% | -3.9% | -3.6% |
| 30D | -3.4% | -0.2% | -3.3% | -3.4% |
| 3M | -8.1% | -4.0% | -4.1% | -7.9% |
| 6M | -11.1% | +20.6% | -31.7% | -12.5% |
| YTD | +0.7% | +10.1% | -9.4% | -0.2% |
| 1Y | +20.1% | +8.8% | +11.4% | +19.0% |
| 3Y | +46.1% | +42.5% | +3.6% | +40.7% |
| 5Y | +48.2% | +61.5% | -13.2% | +40.5% |
| 10Y | +80.1% | +217.6% | -137.5% | +57.8% |
| All | +576.5% | +1,201.8% | -625.3% | +324.1% |
Cumulative growth
Daily Returns
Daily percentage return beside NBIX.
Daily Out/Under-Performance
Portfolio return minus NBIX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NBIX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded NBIX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling